Sign in
Taking peopleNo phase

Swiss Primary Sclerosing Cholangitis Cohort Study

Key facts

Who runs it
Fondazione Epatocentro Ticino
Where
Switzerland21 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
120 people, planned
Started
28 Feb 2017
Expected to end
31 Dec 2030
Type of study
Observational
Record updated
19 August 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
  • patients living in Switzerland

Who cannot take part

  • N/A

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Research project in which biological material is sampled and health-related personal data is further used and collected.

Read full original descriptionShow less

Coded data are used.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
19 August 2025